Name: | Description: | Size: | Format: | |
---|---|---|---|---|
441.09 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Previous studies have shown the usefulness of
the substrate envelope concept in the analysis and
prediction of drug resistance profiles for human
immunodeficiency virus protease mutants. This
study tests its applicability to several other thera peutic targets: Abl kinase, chitinase, thymidylate
synthase, dihydrofolate reductase, and neuramini dase. For the targets where many (‡6) mutation data
are available to compute the average mutation sen sitivity of inhibitors, the total volume of an inhibitor
molecule that projects outside the substrate enve lope Vout, is found to correlate with average muta tion sensitivity. Analysis of a locally computed
volume suggests that the same correlation would
hold for the other targets, if more extensive muta tion data sets were available. It is concluded that
the substrate envelope concept offers a promising
and easily implemented computational tool for
the design of drugs that will tend to resist muta tions. Software implementing these calculations is
provided with the ’Supporting Information’.
Description
Keywords
Mutation resistance Substrate envelope . Faculdade de Ciências Exatas e da Engenharia
Citation
Kairys, V., Gilson, M. K., Lather, V., Schiffer, C. A., & Fernandes, M. X. (2009). Toward the design of mutation‐resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis. Chemical biology & drug design, 74(3), 234-245.
Publisher
Wiley